Webinar

Cooley Market Talks Biotech Financing Environment and Deal Considerations

August 31, 2022
Event details
August 31, 2022

Event summary

Against the backdrop of a prolonged global pandemic, international conflict and a shifting economic climate, the capital markets landscape is ever-changing. Cooley brings you a quarterly webinar series that cuts through the noise and drills down on what you need to know about the current market.

Our inaugural webinar focused on the current biotech financing environment and deal considerations. Our panel of thought leaders provided key insights on financing under current market conditions, including alternative financing structures companies have been turning to and practical considerations in navigating them.

In a world that increasingly identifies with the acronym VUCA, short for: volatility, uncertainty, complexity and ambiguity, this webinar series arms leaders with clear and topical insights to help guide decisions in a quickly shifting market landscape.

Speakers

For more information, please email Andrew Gentilucci.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.